as well as pharmacologically acceptable salts, where X independently denotes a heteroatom selected from O, S or an NH group which forms a five-member heteroarene condensed with an anthracenedione nucleus at bonds 2-3; n independently denotes a number from 2 to 4, which is equal to the number of spacer CH2 groups which link amino groups in peri-positions of heteroarene anthracenedione with nitrogen atoms of guanidine group residues located in side chains; m independently denotes a number from 2 to 4, which is equal to the number of spacer CH2 groups which link the nitrogen atom of a carboxamide group located at position 2 of the heterocyclic nucleus of heteroarene anthracenedione with the nitrogen atom of the guanidine group residue located in the side chain.;EFFECT: obtaining novel compounds which can be used in medicine for therapy of cancerous diseases.;2 tbl, 2 dwg, 8 ex"/> NOVEL HETEROARENE ANTHRACENEDIONE-BASED G-QUADRUPLEX LIGANDS INHIBITING TUMOUR CELL GROWTH
首页> 外国专利> NOVEL HETEROARENE ANTHRACENEDIONE-BASED G-QUADRUPLEX LIGANDS INHIBITING TUMOUR CELL GROWTH

NOVEL HETEROARENE ANTHRACENEDIONE-BASED G-QUADRUPLEX LIGANDS INHIBITING TUMOUR CELL GROWTH

机译:基于新型异戊二烯蒽酮的G-四联配体抑制肿瘤细胞的生长

摘要

FIELD: chemistry.;SUBSTANCE: invention relates to linear heterocyclic anthracenedione derivatives containing guanidino(alkylamino) groups in positions 2, 4 and 11 and having the formula: as well as pharmacologically acceptable salts, where X independently denotes a heteroatom selected from O, S or an NH group which forms a five-member heteroarene condensed with an anthracenedione nucleus at bonds 2-3; n independently denotes a number from 2 to 4, which is equal to the number of spacer CH2 groups which link amino groups in peri-positions of heteroarene anthracenedione with nitrogen atoms of guanidine group residues located in side chains; m independently denotes a number from 2 to 4, which is equal to the number of spacer CH2 groups which link the nitrogen atom of a carboxamide group located at position 2 of the heterocyclic nucleus of heteroarene anthracenedione with the nitrogen atom of the guanidine group residue located in the side chain.;EFFECT: obtaining novel compounds which can be used in medicine for therapy of cancerous diseases.;2 tbl, 2 dwg, 8 ex
机译:技术领域本发明涉及在位置2、4和11上含有胍基(烷基氨基)基团并具有下式的线性杂环蒽二酮衍生物:以及药理上可接受的盐,其中X独立表示选自O,S或NH基团的杂原子,该杂原子形成五元杂芳烃,在键2处与蒽二酮核键合。 -3; n独立地表示2至4的数目,其等于将杂芳烃蒽二酮的周围位置的氨基与位于侧链的胍基残基的氮原子连接的间隔基CH 2 的数目。 ; m独立地表示2至4的数字,其等于将位于杂芳烃蒽二酮的杂环核的2位上的羧酰胺基团的氮原子连接到其上的间隔基CH 2 的数目。效果:获得可用于治疗癌症的药物的新型化合物; 2 tbl,2 dwg,8 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号